Status | Study |
Active, not recruiting |
Study Name: Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Condition: Anemia Chronic Lymphocytic Leukemia Fatigue Date: 2014-01-27 Interventions: Drug: Cyclophosphamide Given I |
No longer available |
Study Name: Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease Condition: Gaucher Disease Date: 2009-08-18 Interventions: Drug: Plant cell expressed recombinant glucocerebrosidase (prGCD) Intravenous infusion every two weeks a |
Completed |
Study Name: Open-Label Extension of LOCKCYST Trial Condition: Polycystic Liver Disease Hepatomegaly Date: 2008-10-13 Interventions: Drug: lanreotide lanreotide |
Completed |
Study Name: Lanreotide as Treatment of Polycystic Livers Condition: Polycystic Liver Disease Hepatomegaly Date: 2007-11-28 Interventions: Drug: Placebo Drug: Lanreotide |
Completed |
Study Name: Octreotide in Severe Polycystic Liver Disease Condition: Polycystic Kidney, Autosomal Dominant Polycystic Liver Disease Date: 2007-01-22 Interventions: Drug: Octreotide Participants |